$AIXN
AiXin Life International, Inc.

2014 Form 10-K Financial Statement

#000114420414052253 Filed on August 25, 2014

View on sec.gov

Income Statement

Concept 2014 2013 Q2 2013
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue $0.00
YoY Change
Gross Profit $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $20.00K $10.00K $20.00K
YoY Change 0.0% 0.0% 0.0%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00
YoY Change
% of Gross Profit
Operating Expenses $20.00K $10.00K $20.00K
YoY Change 0.0% 0.0% 0.0%
Operating Profit -$20.00K
YoY Change
Interest Expense $0.00 $0.00 $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00
YoY Change
Pretax Income -$20.05K -$10.00K -$20.00K
YoY Change 0.25% 0.0% 0.0%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$20.05K -$10.00K -$18.50K
YoY Change 8.36% 0.0% -7.49%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$440.40 -$220.20 -$440.40
COMMON SHARES
Basic Shares Outstanding 45.41M shares 45.41M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 2013 Q2 2013
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $0.00 $0.00
YoY Change
Cash & Equivalents $42.00
Short-Term Investments
Other Short-Term Assets $0.00 $0.00
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $0.00 $0.00 $0.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $42.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $0.00 $0.00 $0.00
Total Long-Term Assets $0.00 $42.00 $0.00
Total Assets $0.00 $42.00 $0.00
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $50.00K $30.00K $30.00K
YoY Change 66.67% 200.0% 200.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $50.00K $30.00K $30.00K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $50.00K $27.77K $30.00K
YoY Change 66.67% 177.66% 200.0%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $454.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$50.00K -$27.72K -$30.00K
YoY Change
Total Liabilities & Shareholders Equity $0.00 $42.00 $0.00
YoY Change

Cashflow Statement

Concept 2014 2013 Q2 2013
OPERATING ACTIVITIES
Net Income -$20.05K -$10.00K -$18.50K
YoY Change 8.36% 0.0% -7.49%
Depreciation, Depletion And Amortization $0.00
YoY Change
Cash From Operating Activities -$21.54K $0.00 -$19.51K
YoY Change 10.41% -2.46%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $23.00K 0.000 $18.50K
YoY Change 24.32% 85.0%
NET CHANGE
Cash From Operating Activities -$21.54K 0.000 -$19.51K
Cash From Investing Activities $0.00 0.000 $0.00
Cash From Financing Activities $23.00K 0.000 $18.50K
Net Change In Cash $1.461K 0.000 -$1.009K
YoY Change -244.8% -89.91%
FREE CASH FLOW
Cash From Operating Activities -$21.54K $0.00 -$19.51K
Capital Expenditures $0.00
Free Cash Flow -$21.54K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q2 us-gaap Cash
Cash
42 USD
CY2014Q2 us-gaap Cash
Cash
1503 USD
CY2013Q2 us-gaap Assets
Assets
42 USD
CY2014Q2 us-gaap Assets
Assets
2851 USD
CY2013Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4266 USD
CY2014Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4124 USD
CY2013Q2 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
23500 USD
CY2014Q2 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
46500 USD
CY2013Q2 us-gaap Liabilities
Liabilities
27766 USD
CY2014Q2 us-gaap Liabilities
Liabilities
50624 USD
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
454 USD
CY2014Q2 us-gaap Common Stock Value
CommonStockValue
454 USD
CY2013Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
158722 USD
CY2014Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
158722 USD
CY2013Q2 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
186900 USD
CY2014Q2 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
206949 USD
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
-27724 USD
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
-47773 USD
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
42 USD
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2851 USD
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2014Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
950000000 shares
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
950000000 shares
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45411400 shares
CY2014Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45411400 shares
us-gaap Revenues
Revenues
0 USD
CY2013 us-gaap Revenues
Revenues
0 USD
CY2014 us-gaap Revenues
Revenues
0 USD
CY2013 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1007 USD
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20049 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
79850 USD
CY2014 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-142 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
1470 USD
CY2013 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
0 USD
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-18502 USD
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.0004
CY2013 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
18500 USD
CY2014 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
23000 USD
us-gaap Net Income Loss
NetIncomeLoss
-206949 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
205479 USD
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18502 USD
us-gaap Interest Expense
InterestExpense
1470 USD
CY2013 us-gaap Interest Expense
InterestExpense
0 USD
CY2014 us-gaap Interest Expense
InterestExpense
0 USD
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-20049 USD
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.0004
CY2013 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45411400 shares
CY2014 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45411400 shares
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-14842 USD
CY2014 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
0 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-221669 USD
CY2013 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19509 USD
CY2014 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21539 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
CY2013 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
CY2014 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
610 USD
CY2014 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
223062 USD
CY2013 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
18500 USD
CY2014 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
23000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1393 USD
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1009 USD
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1461 USD
CY2004Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
110 USD
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1051 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
42 USD
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1503 USD
us-gaap Interest Paid
InterestPaid
0 USD
CY2013 us-gaap Interest Paid
InterestPaid
0 USD
CY2014 us-gaap Interest Paid
InterestPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2013 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2014 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
20000 USD
CY2013 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
CY2014 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
68822 USD
CY2013 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2014 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
55000 USD
CY2013 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
0 USD
CY2013 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0 USD
CY2014 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0 USD
CY2014Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
30825 USD
CY2013Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2014Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2013 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-2775 USD
CY2014 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-3000 USD
CY2013 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-2775 USD
CY2014 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-3000 USD
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2014 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="COLOR: black"><u>Pervasiveness of Estimates</u></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="COLOR: black">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="COLOR: black">The preparation of financial statements, in conformity with generally accepted accounting principles, required management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2013Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
27825 USD
CY2014Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
30825 USD
CY2013Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
27825 USD
CY2014 dei Document Type
DocumentType
10-K
CY2014 dei Amendment Flag
AmendmentFlag
false
CY2014 dei Document Period End Date
DocumentPeriodEndDate
2014-05-31
CY2014 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2014 dei Entity Registrant Name
EntityRegistrantName
MERCARI COMMUNICATIONS GROUP LTD
CY2014 dei Entity Central Index Key
EntityCentralIndexKey
0000835662
CY2014 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--05-31
CY2014 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2014 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2014 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2014 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2014Q2 dei Entity Public Float
EntityPublicFloat
0 USD
CY2014 dei Trading Symbol
TradingSymbol
MCAR
CY2014Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
45411400 shares
CY2013Q2 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
0 USD
CY2014Q2 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
1348 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1348 USD
CY2014 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1348 USD
mcar Proceeds From Shareholders Advances
ProceedsFromShareholdersAdvances
46500 USD
CY2014 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Expense
UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
0 USD
CY2008Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
3.5 to 1
CY2014Q3 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
900 to 1
CY2008Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
5729 shares
CY2001Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
64524 shares
CY2001Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
240945 shares
CY2001Q4 mcar Cash Consideration For Shares Authorized
CashConsiderationForSharesAuthorized
7590 USD
CY2007Q1 mcar Stock Issued During Period Shares For Notes Payable
StockIssuedDuringPeriodSharesForNotesPayable
571428 shares
CY2009Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
43822001 shares
CY2014Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
205500 USD
CY2008Q2 us-gaap Stock Issued During Period Shares Reverse Stock Splits
StockIssuedDuringPeriodSharesReverseStockSplits
5729 shares
CY2014 mcar Operating Loss Carryforwards Expiration Year
OperatingLossCarryforwardsExpirationYear
2034

Files In Submission

Name View Source Status
0001144204-14-052253-index-headers.html Edgar Link pending
0001144204-14-052253-index.html Edgar Link pending
0001144204-14-052253.txt Edgar Link pending
0001144204-14-052253-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
mcar-20140531.xml Edgar Link completed
mcar-20140531.xsd Edgar Link pending
mcar-20140531_cal.xml Edgar Link unprocessable
mcar-20140531_def.xml Edgar Link unprocessable
mcar-20140531_lab.xml Edgar Link unprocessable
mcar-20140531_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v387427_10k.htm Edgar Link pending
v387427_ex31-1.htm Edgar Link pending
v387427_ex31-2.htm Edgar Link pending
v387427_ex32-1.htm Edgar Link pending
v387427_ex32-2.htm Edgar Link pending